Skip to main content

Table 1 Characteristics of the PCOS patients receiving IVM treatment

From: Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome

 

hCG-primed group

Non-primed group

p

Patients

40

42

 

age (years)

30.03 ± 3.65

30.33 ± 3.71

ns

BMI (kg/m2)

24.93 ± 4.94

25.37 ± 5.75

ns

No. of primary infertility (%)

34 (85.00)

37 (88.10)

ns

Basal FSH (IU/mL)

5.57 ± 1.76

6.08 ± 1.66

ns

Antral follicle count

22.60 ± 5.93

22.76 ± 5.99

ns

No. of anovulatory (%)

36 (90.00)

34 (80.95)

ns

No. of patients with biochemical hyperandrogenism (%)

25 (62.5)

20 (47.62)

ns